METASTATIC BREAST CARCINOMA
Clinical trials for METASTATIC BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Bone-Seeking' radiation drug enters human trials for advanced cancers
Disease control Not yet recruitingThis is a first-in-human study to find a safe dose of a new radioactive drug, Sn-117m-DTPA, for patients whose prostate, breast, or non-small cell lung cancer has spread to their bones. The drug is designed to deliver radiation directly to bone tumors while trying to spare the he…
Matched conditions: METASTATIC BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Radioactive 'Tumor Hunter' drug tested in advanced breast cancer patients
Disease control Not yet recruitingThis study is testing a new, targeted radioactive drug called 177Lu-DOTATATE in patients with advanced breast cancer that has spread or returned. The drug is designed to seek out and attach to specific cancer cells, delivering radiation directly to the tumor to try to shrink it a…
Matched conditions: METASTATIC BREAST CARCINOMA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC